81219 Calr gene com variants
Also known as: CALR common variant testing, CALR mutation panel
Molecular analysis of the CALR gene to identify common mutations (insertions and deletions) associated with essential thrombocythemia and primary myelofibrosis.
In Plain Language
blood clot disorder gene test; myeloproliferative disease screening
Clinical Context
Used to identify CALR mutations in myeloproliferative neoplasms for diagnosis and prognosis determination in patients with thrombocytosis.
RVU Information
CPT 81219 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81219?
CPT 81219 (Calr gene com variants) is a Pathology & Lab code. Molecular analysis of the CALR gene to identify common mutations (insertions and deletions) associated with essential thrombocythemia and primary myelofibrosis.
Who uses CPT code 81219?
CPT 81219 is used by Hematology, Oncology, Pathology. Used to identify CALR mutations in myeloproliferative neoplasms for diagnosis and prognosis determination in patients with thrombocytosis.
When is CPT 81219 used?
Used to identify CALR mutations in myeloproliferative neoplasms for diagnosis and prognosis determination in patients with thrombocytosis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.